Clinical Trial Update: hsCRP in Japan Statin Treatment Against Recurrent Stroke (J-STARS hsCRP) [Phase 3]

View source ↗

Summary

Phase 3 J-STARS hsCRP trial in Japan assessing statin therapy for preventing recurrent ischemic stroke; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Pravastatin (pravastatin)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED